标题
Targeting the oncogenic Met receptor by antibodies and gene therapy
作者
关键词
-
出版物
ONCOGENE
Volume 34, Issue 15, Pages 1883-1889
出版商
Springer Nature
发表日期
2014-06-02
DOI
10.1038/onc.2014.142
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Issue Information
- (2015) JOURNAL OF CLINICAL PHARMACOLOGY
- Discovery of Fully Human Anti-MET Monoclonal Antibodies with Antitumor Activity against Colon Cancer Tumor Models In Vivo
- (2015) Edward Htun van der Horst et al. NEOPLASIA
- MET Signaling in Colon Cancer Stem-like Cells Blunts the Therapeutic Response to EGFR Inhibitors
- (2014) Paolo Luraghi et al. CANCER RESEARCH
- Targeting of the MET receptor tyrosine kinase by small molecule inhibitors leads to MET accumulation by impairing the receptor downregulation
- (2014) Dominic Leiser et al. FEBS LETTERS
- Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer
- (2013) Xiongyan Wu et al. CANCER LETTERS
- Preclinical Efficacy of the Anti-Hepatocyte Growth Factor Antibody Ficlatuzumab in a Mouse Brain Orthotopic Glioma Model Evaluated by Bioluminescence, PET, and MRI
- (2013) E. S. Mittra et al. CLINICAL CANCER RESEARCH
- Treatment Rationale and Study Design for a Randomized, Double-Blind, Placebo-Controlled Phase II Study Evaluating Onartuzumab (MetMAb) in Combination With Bevacizumab Plus mFOLFOX-6 in Patients With Previously Untreated Metastatic Colorectal Cancer
- (2013) Johanna C. Bendell et al. Clinical Colorectal Cancer
- Anti-c-MET Nanobody®- a new potential drug in multiple myeloma treatment
- (2013) Tobias Schmidt Slørdahl et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study
- (2013) Lainie P. Martin et al. GYNECOLOGIC ONCOLOGY
- MET As a Possible Target for Non–Small-Cell Lung Cancer
- (2013) Ahad A. Sadiq et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted therapy by gene transfer of a monovalent antibody fragment against the Met oncogenic receptor
- (2013) Elisa Vigna et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- From Bench to Bedside: Does Preclinical Practice in Translational Oncology Need Some Rebuilding?
- (2013) A. Bertotti et al. JNCI-Journal of the National Cancer Institute
- A novel bispecific EGFR/Met antibody blocks tumor-promoting phenotypic effects induced by resistance to EGFR inhibition and has potent antitumor activity
- (2013) R Castoldi et al. ONCOGENE
- Initial testing (Stage 1) of TAK-701, a humanized hepatocyte growth factor binding antibody, by the pediatric preclinical testing program
- (2013) Peter J. Houghton et al. PEDIATRIC BLOOD & CANCER
- Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent
- (2013) M. Merchant et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome
- (2013) A. Aiuti et al. SCIENCE
- Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
- (2013) A. Biffi et al. SCIENCE
- Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
- (2013) Alberto Bardelli et al. Cancer Discovery
- The MET Oncogene Is a Functional Marker of a Glioblastoma Stem Cell Subtype
- (2012) F. De Bacco et al. CANCER RESEARCH
- Targeted MET Inhibition in Castration-Resistant Prostate Cancer: A Randomized Phase II Study and Biomarker Analysis with Rilotumumab plus Mitoxantrone and Prednisone
- (2012) C. J. Ryan et al. CLINICAL CANCER RESEARCH
- Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy
- (2012) M. J. W. D. Vosjan et al. MOLECULAR CANCER THERAPEUTICS
- MET: a promising anticancer therapeutic target
- (2012) Solange Peters et al. Nature Reviews Clinical Oncology
- Cbl-independent degradation of Met: ways to avoid agonism of bivalent Met-targeting antibody
- (2012) J M Lee et al. ONCOGENE
- Non-Agonistic Bivalent Antibodies That Promote c-MET Degradation and Inhibit Tumor Growth and Others Specific for Tumor Related c-MET
- (2012) Sameer A. Greenall et al. PLoS One
- Shedding-Generated Met Receptor Fragments can be Routed to Either the Proteasomal or the Lysosomal Degradation Pathway
- (2012) Frédéric Ancot et al. TRAFFIC
- METAmplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib
- (2011) Jochen K. Lennerz et al. JOURNAL OF CLINICAL ONCOLOGY
- Induction of MET by Ionizing Radiation and Its Role in Radioresistance and Invasive Growth of Cancer
- (2011) Francesca De Bacco et al. JNCI-Journal of the National Cancer Institute
- Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression
- (2011) Rui Wang et al. LUNG CANCER
- A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma
- (2011) P. Y. Wen et al. NEURO-ONCOLOGY
- Durable Complete Response of Metastatic Gastric Cancer with Anti-Met Therapy Followed by Resistance at Recurrence
- (2011) D. V. T. Catenacci et al. Cancer Discovery
- A Phase Ib Study of AMG 102 in Combination with Bevacizumab or Motesanib in Patients with Advanced Solid Tumors
- (2010) P. J. Rosen et al. CLINICAL CANCER RESEARCH
- MET mutations in cancers of unknown primary origin (CUPs)
- (2010) Giulia M. Stella et al. HUMAN MUTATION
- Monovalency Unleashes the Full Therapeutic Potential of the DN-30 Anti-Met Antibody
- (2010) Giovanni Pacchiana et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Disintegrin and Metalloproteinase-10 (ADAM-10) Mediates DN30 Antibody-induced Shedding of the Met Surface Receptor
- (2010) Florian Schelter et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102
- (2010) Ian M. Buchanan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Biochemical Characterization of AMG 102: A Neutralizing, Fully Human Monoclonal Antibody to Human and Nonhuman Primate Hepatocyte Growth Factor
- (2010) T. L. Burgess et al. MOLECULAR CANCER THERAPEUTICS
- TAK-701, a Humanized Monoclonal Antibody to Hepatocyte Growth Factor, Reverses Gefitinib Resistance Induced by Tumor-Derived HGF in Non-Small Cell Lung Cancer with an EGFR Mutation
- (2010) W. Okamoto et al. MOLECULAR CANCER THERAPEUTICS
- Repeated hepatocyte growth factor neutralizing antibody treatment leads to HGF/SF unresponsiveness in human glioblastoma multiforme cells
- (2009) Ping Zhao et al. CANCER LETTERS
- Down-Regulation of the Met Receptor Tyrosine Kinase by Presenilin-dependent Regulated Intramembrane Proteolysis
- (2009) Bénédicte Foveau et al. MOLECULAR BIOLOGY OF THE CELL
- The cancer genome
- (2009) Michael R. Stratton et al. NATURE
- MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival
- (2008) H. Jin et al. CANCER RESEARCH
- "Active" Cancer Immunotherapy by Anti-Met Antibody Gene Transfer
- (2008) E. Vigna et al. CANCER RESEARCH
- Single-Agent and Combination Therapeutic Strategies to Inhibit Hepatocyte Growth Factor/MET Signaling in Cancer
- (2008) L. Toschi et al. CLINICAL CANCER RESEARCH
- Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30
- (2008) Lars R. Perk et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The ADAM metalloproteinases
- (2008) D EDWARDS et al. MOLECULAR ASPECTS OF MEDICINE
- Drug development of MET inhibitors: targeting oncogene addiction and expedience
- (2008) Paolo M. Comoglio et al. NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now